Podcast
Questions and Answers
Which of the following is true about Q-bodies?
Which of the following is true about Q-bodies?
- Q-bodies are a protective response to misfolded proteins (correct)
- Q-bodies are the final form of protein degradation
- Q-bodies are formed during protein refolding
- Q-bodies are primarily found in neuronal orglial cell types
What is the purpose of aggresome/inclusion bodies?
What is the purpose of aggresome/inclusion bodies?
- To promote protein refolding
- To transport misfolded proteins to the nucleus
- To protect misfolded proteins (correct)
- To degrade misfolded proteins
Which protein unloads polyubiquitination from aggregated proteins?
Which protein unloads polyubiquitination from aggregated proteins?
- TRIM5O
- P97 (correct)
- LC3
- Poh1
What happens to aggregated proteins during retrograde transport?
What happens to aggregated proteins during retrograde transport?
What is the role of Poh1 in aggresome formation?
What is the role of Poh1 in aggresome formation?
What mediates the clearance of aggresomes?
What mediates the clearance of aggresomes?
What happens if there is trouble with aggresome clearance?
What happens if there is trouble with aggresome clearance?
Which protein is associated with the formation of cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
Which protein is associated with the formation of cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
Which genetic mutation is responsible for causing 5-10% of Parkinson's disease cases?
Which genetic mutation is responsible for causing 5-10% of Parkinson's disease cases?
Which protein is associated with the formation of intraneuronal neurofibrillary tangles and extracellular amyloid plaques in Alzheimer's disease?
Which protein is associated with the formation of intraneuronal neurofibrillary tangles and extracellular amyloid plaques in Alzheimer's disease?
Which enzyme is targeted by cholinesterase inhibitors in the treatment of Alzheimer's disease?
Which enzyme is targeted by cholinesterase inhibitors in the treatment of Alzheimer's disease?
Which trinucleotide expansion is associated with Huntington's disease?
Which trinucleotide expansion is associated with Huntington's disease?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
Which intracellular protein degradation pathway involves the use of the p62 adapter protein and the lysosome?
Which intracellular protein degradation pathway involves the use of the p62 adapter protein and the lysosome?
Which protein is the main aggregating protein in inclusion bodies in many neurodegenerative diseases?
Which protein is the main aggregating protein in inclusion bodies in many neurodegenerative diseases?
What is the proposed link between a-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
What is the proposed link between a-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
What is the technique used to measure very small structures such as protein aggregates?
What is the technique used to measure very small structures such as protein aggregates?
Which type of autophagy involves membrane formation around organelles and their engulfment by lysosomes?
Which type of autophagy involves membrane formation around organelles and their engulfment by lysosomes?
What is the role of SUMO-1 modification of proteins in neurodegeneration?
What is the role of SUMO-1 modification of proteins in neurodegeneration?
How do metal ions, such as calcium, copper, and zinc, contribute to neurodegeneration?
How do metal ions, such as calcium, copper, and zinc, contribute to neurodegeneration?
What is the role of ATP7a/b pump in neurodegenerative diseases?
What is the role of ATP7a/b pump in neurodegenerative diseases?
Which of the following is a key feature of the cell-to-cell spread of alpha-synuclein in PD and MSA?
Which of the following is a key feature of the cell-to-cell spread of alpha-synuclein in PD and MSA?
What is the potential role of exosomes in the spread of aggregate protein?
What is the potential role of exosomes in the spread of aggregate protein?
How can PARK9 mutations contribute to synuclein release from exosomes?
How can PARK9 mutations contribute to synuclein release from exosomes?
What is one of the links between neuroinflammation and neurodegeneration in AD and MSA?
What is one of the links between neuroinflammation and neurodegeneration in AD and MSA?
What is an activated marker of inflammation in the brain?
What is an activated marker of inflammation in the brain?
How can the use of NSAIDs potentially lessen the risk of AD?
How can the use of NSAIDs potentially lessen the risk of AD?
What can cause an increased expression of the cytoskeletal protein GFAP in the CNS?
What can cause an increased expression of the cytoskeletal protein GFAP in the CNS?
Which of the following is true about the cell-to-cell spread of alpha-synuclein?
Which of the following is true about the cell-to-cell spread of alpha-synuclein?
What is the potential role of exosomes in the spread of alpha-synuclein in PD and MSA?
What is the potential role of exosomes in the spread of alpha-synuclein in PD and MSA?
Which of the following is true about Q-bodies?
Which of the following is true about Q-bodies?
What is the purpose of aggresome/inclusion bodies?
What is the purpose of aggresome/inclusion bodies?
What is the role of P62 adapter protein in aggresome formation?
What is the role of P62 adapter protein in aggresome formation?
What is the main aggregating protein in inclusion bodies in many neurodegenerative diseases?
What is the main aggregating protein in inclusion bodies in many neurodegenerative diseases?
What is the proposed link between a-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
What is the proposed link between a-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
What is the technique used to measure very small structures such as protein aggregates?
What is the technique used to measure very small structures such as protein aggregates?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
Which protein is associated with the formation of cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
Which protein is associated with the formation of cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
Which trinucleotide expansion is associated with Huntington's disease?
Which trinucleotide expansion is associated with Huntington's disease?
Which protein is associated with the formation of intraneuronal neurofibrillary tangles and extracellular amyloid plaques in Alzheimer's disease?
Which protein is associated with the formation of intraneuronal neurofibrillary tangles and extracellular amyloid plaques in Alzheimer's disease?
Which enzyme is targeted by cholinesterase inhibitors in the treatment of Alzheimer's disease?
Which enzyme is targeted by cholinesterase inhibitors in the treatment of Alzheimer's disease?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
What is the technique used to measure very small structures such as protein aggregates?
What is the technique used to measure very small structures such as protein aggregates?
What is the role of ATP7a/b pump in neurodegenerative diseases?
What is the role of ATP7a/b pump in neurodegenerative diseases?
Which of the following is a proposed link between alpha-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
Which of the following is a proposed link between alpha-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
What is the proposed link between metal ions, such as calcium, copper, zinc, and neurodegeneration?
What is the proposed link between metal ions, such as calcium, copper, zinc, and neurodegeneration?
What is the role of SUMO-1 modification of proteins in neurodegeneration?
What is the role of SUMO-1 modification of proteins in neurodegeneration?
What is the proposed link between alpha-synuclein mutants in PD and CMA?
What is the proposed link between alpha-synuclein mutants in PD and CMA?
What is the role of autophagy in clearing polyQ aggregates?
What is the role of autophagy in clearing polyQ aggregates?
What is the proposed link between alpha-synuclein and neurotransmitter vesicles?
What is the proposed link between alpha-synuclein and neurotransmitter vesicles?
What is the proposed link between alpha-synuclein and the 19s cap of the proteasome?
What is the proposed link between alpha-synuclein and the 19s cap of the proteasome?
Which of the following is true about the cell-to-cell spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
Which of the following is true about the cell-to-cell spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
Which genetic mutation can lead to synuclein release from exosomes?
Which genetic mutation can lead to synuclein release from exosomes?
What is the role of neuroinflammation in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Multiple System Atrophy (MSA)?
What is the role of neuroinflammation in neurodegenerative diseases, particularly Alzheimer's disease (AD) and Multiple System Atrophy (MSA)?
Which of the following can lessen the risk of Alzheimer's disease (AD)?
Which of the following can lessen the risk of Alzheimer's disease (AD)?
What is the potential role of exosomes in the spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
What is the potential role of exosomes in the spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
What is the key feature of the cell-to-cell spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
What is the key feature of the cell-to-cell spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
What is the proposed link between alpha-synuclein oligomers, pore formation, UPS inhibition, and Parkinson's disease (PD) pathogenesis?
What is the proposed link between alpha-synuclein oligomers, pore formation, UPS inhibition, and Parkinson's disease (PD) pathogenesis?
How do metal ions, such as calcium, copper, and zinc, contribute to neurodegeneration?
How do metal ions, such as calcium, copper, and zinc, contribute to neurodegeneration?
What can cause an increased expression of the cytoskeletal protein GFAP in the central nervous system (CNS)?
What can cause an increased expression of the cytoskeletal protein GFAP in the central nervous system (CNS)?
Which of the following is the correct sequence of events in aggresome formation and degradation?
Which of the following is the correct sequence of events in aggresome formation and degradation?
Which organelle is involved in the clearance of aggresomes?
Which organelle is involved in the clearance of aggresomes?
Which protein is involved in the unloading of polyubiquitinated proteins from aggresomes?
Which protein is involved in the unloading of polyubiquitinated proteins from aggresomes?
What is the role of the P62 adapter protein in aggresome formation?
What is the role of the P62 adapter protein in aggresome formation?
What happens if there is trouble with aggresome clearance?
What happens if there is trouble with aggresome clearance?
What is the proposed link between alpha-synuclein mutants and aggresome formation?
What is the proposed link between alpha-synuclein mutants and aggresome formation?
What is the intermediate form between protein refolding and degradation?
What is the intermediate form between protein refolding and degradation?
Which protein is associated with cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
Which protein is associated with cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
What is the main aggregating protein in intraneuronal neurofibrillary tangles and extracellular amyloid plaques in Alzheimer's disease?
What is the main aggregating protein in intraneuronal neurofibrillary tangles and extracellular amyloid plaques in Alzheimer's disease?
What is the trinucleotide expansion associated with Huntington's disease?
What is the trinucleotide expansion associated with Huntington's disease?
Which enzyme is targeted by cholinesterase inhibitors in the treatment of Alzheimer's disease?
Which enzyme is targeted by cholinesterase inhibitors in the treatment of Alzheimer's disease?
What is the role of PINK1 mutation in Parkinson's disease?
What is the role of PINK1 mutation in Parkinson's disease?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
Which protein is associated with about 20% of familial cases of amyotrophic lateral sclerosis (ALS)?
What is the main mechanism of intracellular protein degradation via the ubiquitin-proteasome system (UPS)?
What is the main mechanism of intracellular protein degradation via the ubiquitin-proteasome system (UPS)?
Which of the following is a key feature of macroautophagy?
Which of the following is a key feature of macroautophagy?
What is the proposed link between SUMO-1 modification of proteins and neurodegeneration?
What is the proposed link between SUMO-1 modification of proteins and neurodegeneration?
What is the proposed link between metal ions and neurodegeneration?
What is the proposed link between metal ions and neurodegeneration?
What is the role of ATP7a/b pump in neurodegenerative diseases?
What is the role of ATP7a/b pump in neurodegenerative diseases?
What is the proposed link between alpha-synuclein mutants in PD and CMA?
What is the proposed link between alpha-synuclein mutants in PD and CMA?
What is the proposed link between a-synuclein oligomers and UPS inhibition?
What is the proposed link between a-synuclein oligomers and UPS inhibition?
What is the proposed link between alpha-synuclein and neurotransmitter vesicles?
What is the proposed link between alpha-synuclein and neurotransmitter vesicles?
Which of the following is a key feature of the cell-to-cell spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
Which of the following is a key feature of the cell-to-cell spread of alpha-synuclein in Parkinson's disease (PD) and Multiple System Atrophy (MSA)?
What is the proposed link between alpha-synuclein mutants in PD and CMA?
What is the proposed link between alpha-synuclein mutants in PD and CMA?
What is the role of Poh1 in aggresome formation?
What is the role of Poh1 in aggresome formation?
What is the main aggregating protein in inclusion bodies in many neurodegenerative diseases?
What is the main aggregating protein in inclusion bodies in many neurodegenerative diseases?
What is the proposed link between alpha-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
What is the proposed link between alpha-synuclein oligomers, pore formation, UPS inhibition, and PD pathogenesis?
How can the use of NSAIDs potentially lessen the risk of AD?
How can the use of NSAIDs potentially lessen the risk of AD?
What is the potential role of exosomes in the spread of alpha-synuclein in PD and MSA?
What is the potential role of exosomes in the spread of alpha-synuclein in PD and MSA?
Which protein is associated with the formation of cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
Which protein is associated with the formation of cytoplasmic inclusions called Lewy bodies in Parkinson's disease?
What is the role of SUMO-1 modification of proteins in neurodegeneration?
What is the role of SUMO-1 modification of proteins in neurodegeneration?